American Psychiatric Association Publishing

Engaging case studies drawn from the real-world practice of a diverse group of experts bring DSM-5-TRto life in this exhaustive new volume. Designed to familiarize undergraduate, graduate, and postgraduate students in psychology, psychiatry, social work, counseling, and psychiatric nursing with the diagnosis of psychopathology, this guide is equally useful for experienced clinicians seeking to improve their understanding of the new concepts and terminology in DSM-5-TR. Organized according to the order of the 19 diagnostic groupings as they appear in DSM-5-TR, this book includes at least one case for each unique mental disorder listed in DSM-5-TR. In each richly detailed chapter, readers will find: • An overview of the manifestation of the various disorders included in the corresponding disorder class• A table summarizing key characteristics of each individual disorder• Comprehensive sections on the individual disorders that describe hallmark features, prevalence data, clinical course, and commonly occurring disorders, among other topics Multiple cases are included for more than one-third of the DSM disorders to illustrate heterogeneity in the presentation. For example, there are six different cases of Bipolar I Disorder; these include cases with mood-congruent and mood-incongruent psychotic features, with catatonia, with rapid cycling, with development during treatment with an antidepressant, and with late-life onset. Distinctive to this edition are four new, cutting-edge cases (illustrating Attenuated Psychosis Syndrome, Internet Gaming Disorder, Olfactory Reference Disorder, and Compulsive Sexual Behavior Disorder) drawn from the "Conditions for Further Study" chapter in DSM-5-TR and from the current edition of the World Health Organization's International Classification of Diseases, 11th revision. The book concludes with an alphabetical index of case names and a comprehensive index of diagnoses with their related cases for ease of reference. Unmatched in its scope and detail, Learning DSM-5-TR by Case Example is an essential resource for all those looking to translate the latest diagnostic concepts and criteria to real-world practice.

Synthesizing the latest research and literature, Treating Addiction to Tobacco and Nicotine Products provides a comprehensive analysis of assessing and treating tobacco use disorder. Smoking rates have declined for decades, yet smoking remains the leading cause of preventable death in the United States, responsible for more 400,000 premature deaths annually in this country and more than 4.9 million deaths worldwide. Featuring numerous case vignettes that bring the topics to life, this volume covers: • Trends in cigarette smoking and its associated harms• Patterns of use, addictiveness, and health effects of non-cigarette tobacco products, including e-cigarettes, cigars, and pipes• Assessing tobacco use disorder• Behavioral and pharmacological interventions for tobacco use disorder• The need for systems change in health care settings Special emphasis is placed on individuals with mental illness, who are disproportionately represented among users of tobacco products. The book explores tobacco use in this population and explains the impact of this comorbidity on treatment and cessation. With summary key points at the end of each chapter to distill clinical highlights, Treating Addiction to Tobacco and Nicotine Products is an essential resource for busy clinicians across various health care disciplines.

Borderline personality disorder (BPD) is estimated to have a lifetime prevalence in the United States of approximately 1.4%–2.7%. It is characterized by a long-term pattern of instability in interpersonal relationships, unstable self-image, marked impulsivity, and/or affective instability. In addition, features can be evidenced by efforts to avoid real or feared abandonment, chronic feelings of emptiness, mood reactivity, recurrent self-injurious or suicidal behavior, other impulsive behaviors with potential for self-damaging effects, intense anger or difficulty with anger control, and transient paranoid ideation or stress-related dissociative symptoms. Although these manifestations can be quite heterogeneous, the lived experience of BPD can be associated with significant emotional pain and a diminished quality of life. Many individuals with BPD have co-occurring psychiatric or somatic conditions, and all-cause mortality is increased among those with BPD. Furthermore, the lifetime burden and psychosocial impairment associated with BPD can be substantial because it typically has an early onset and can persist for many years. These significant consequences support the need for early identification of BPD. Importantly, in contrast to many earlier views on BPD, treatment is effective, and symptoms can be reduced and managed. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Borderline Personality Disorder reviews current evidence and provides evidence-based statements that are intended to optimize the treatment of BPD. The guideline focuses on evidence-based treatments and includes additional information on assessment and treatment planning, which are an integral part of patient-centered care. It describes approaches to implementing recommendations and suggestions in clinical practice. By providing up-to-date knowledge, the guideline aims to help clinicians feel more confident in their skills for treating patients with BPD, thereby improving the care and well-being of their patients.